Andy Pasternak joined Horizon in November 2019. Before joining Horizon, Pasternak led the health care practice in the Americas at Bain & Company Inc., a global management consulting firm. At Bain, he advised boards of directors, CEOs and leadership teams at biopharmaceutical and medical technology companies, as well as private investment funds. His experience spans growth strategy, M&A strategy and execution, organizational design, executive and board governance and performance improvement. Pasternak was also a member of Bain’s Mergers and Acquisition practice, where he served as a leading expert on biopharmaceutical transactions, including acquisitions, business development, licensing deals and divestitures.
Before joining Bain, Pasternak was a founding partner in the Health & Life Sciences practice at Oliver Wyman, a global management consultancy. He also worked in the corporate finance group of J.P. Morgan Securities.
Throughout his career, Pasternak has worked across a wide range of specialty therapeutic areas (including rare diseases) and functions, including commercial, operations and R&D.
Pasternak earned a Master of Business Administration from the University of Chicago and a Bachelor of Arts in economics from Northwestern University.
What is Andy Pasternak's net worth?
The estimated net worth of Andy Pasternak is at least $6.55 million as of January 17th, 2023. Mr. Pasternak owns 56,338 shares of Horizon Therapeutics Public stock worth more than $6,552,109 as of November 15th. This net worth evaluation does not reflect any other assets that Mr. Pasternak may own. Additionally, Mr. Pasternak receives an annual salary of $1,400,000.00 as EVP at Horizon Therapeutics Public. Learn More about Andy Pasternak's net worth.
How old is Andy Pasternak?
Mr. Pasternak is currently 52 years old. There are 6 older executives and no younger executives at Horizon Therapeutics Public. The oldest executive at Horizon Therapeutics Public is Mr. Timothy P. Walbert, Chairman, Pres & CEO, who is 56 years old. Learn More on Andy Pasternak's age.
What is Andy Pasternak's salary?
As the EVP of Horizon Therapeutics Public Limited, Mr. Pasternak earns $1,400,000.00 per year. There are 3 executives that earn more than Mr. Pasternak. The highest earning executive at Horizon Therapeutics Public is Mr. Sean M. Clayton J.D., Exec. VP & Gen. Counsel, who commands a salary of $7,030,000.00 per year. Learn More on Andy Pasternak's salary.
How do I contact Andy Pasternak?
Has Andy Pasternak been buying or selling shares of Horizon Therapeutics Public?
Andy Pasternak has not been actively trading shares of Horizon Therapeutics Public in the last ninety days. Most recently, Andy Pasternak sold 27,129 shares of the business's stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $113.03, for a transaction totalling $3,066,390.87. Following the completion of the sale, the executive vice president now directly owns 56,338 shares of the company's stock, valued at $6,367,884.14. Learn More on Andy Pasternak's trading history.
Who are Horizon Therapeutics Public's active insiders?
Horizon Therapeutics Public's insider roster includes Brian Beeler (EVP), Daniel Camardo (EVP), Sean Clayton (EVP), Aaron Cox (CFO), Geoffrey Curtis (EVP), William Daniel (Director), Michael Desjardin (EVP), Michael Grey (Director), Paul Hoelscher (CFO), Vikram Karnani (EVP), Jeff Kent (Insider), Irina Konstantinovsky (EVP), Miles Mchugh (SVP), Barry Moze (EVP), Andy Pasternak (EVP), Jeffrey Sherman (EVP), Elizabeth Thompson (EVP), and Timothy Walbert (CEO). Learn More on Horizon Therapeutics Public's active insiders.
